97 related articles for article (PubMed ID: 8011545)
1. Interleukin 8 in serum in granulocytopenic patients with infections.
Waage A; Remick D; Steinshamn S; Deforge L; Lamvik J
Br J Haematol; 1994 Jan; 86(1):36-40. PubMed ID: 8011545
[TBL] [Abstract][Full Text] [Related]
2. Soluble tumour necrosis factor receptors, tumour necrosis factor and interleukin-6 in serum in granulocytopenic patients with fever.
Steinshamn S; Brekke OL; Waage A
Br J Haematol; 1995 Apr; 89(4):719-24. PubMed ID: 7772508
[TBL] [Abstract][Full Text] [Related]
3. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.
Engel A; Mack E; Kern P; Kern WV
Infection; 1998; 26(4):213-21. PubMed ID: 9717678
[TBL] [Abstract][Full Text] [Related]
4. Regulated plasma levels of colony-stimulating factors, interleukin-6 and interleukin-10 in patients with acute leukaemia and non-hodgkin's lymphoma undergoing cytoreductive chemotherapy.
Reisbach G; Kamp T; Welzl G; Geiz C; Abedinpour Fariborz ; Lodri A; Kaboth W; Dörmer P; Nerl C
Br J Haematol; 1996 Mar; 92(4):907-12. PubMed ID: 8616084
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
6. Increase in interleukin-6 serum level preceding fever in granulocytopenia and correlation with death from sepsis.
Steinmetz HT; Herbertz A; Bertram M; Diehl V
J Infect Dis; 1995 Jan; 171(1):225-8. PubMed ID: 7798669
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum during induction treatment of acute leukaemia.
Sallerfors B; Olofsson T
Br J Haematol; 1991 Jul; 78(3):343-51. PubMed ID: 1714757
[TBL] [Abstract][Full Text] [Related]
8. Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study.
Ohno R; Miyawaki S; Hatake K; Kuriyama K; Saito K; Kanamaru A; Kobayashi T; Kodera Y; Nishikawa K; Matsuda S; Yamada O; Omoto E; Takeyama H; Tsukuda K; Asou N; Tanimoto M; Shiozaki H; Tomonaga M; Masaoka T; Miura Y; Takaku F; Ohashi Y; Motoyoshi K
J Clin Oncol; 1997 Aug; 15(8):2954-65. PubMed ID: 9256140
[TBL] [Abstract][Full Text] [Related]
9. Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropenia.
Gillis S; Dann EJ; Rund D
Am J Hematol; 1996 Jan; 51(1):26-31. PubMed ID: 8571934
[TBL] [Abstract][Full Text] [Related]
10. Infections in acute myeloid leukemia. Study of 184 febrile episodes.
Kumar L; Kochupillai V; Bhujwala RA
J Assoc Physicians India; 1992 Jan; 40(1):18-20. PubMed ID: 1634456
[TBL] [Abstract][Full Text] [Related]
11. Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients.
Eggimann P; Glauser MP; Aoun M; Meunier F; Calandra T
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():151-63. PubMed ID: 8150759
[TBL] [Abstract][Full Text] [Related]
12. Elderly haematological patients with chemotherapy-induced febrile neutropenia have similar rates of infection and outcome to younger adults: a prospective study of risk-adapted therapy.
García-Suárez J; Krsnik I; Reyes E; De Miguel D; Hernanz N; Barr-Alí M; Burgaleta C
Br J Haematol; 2003 Jan; 120(2):209-16. PubMed ID: 12542477
[TBL] [Abstract][Full Text] [Related]
13. Typhlitis.
Schwartz IS
N Y State J Med; 1989 Jul; 89(7):426. PubMed ID: 2548132
[No Abstract] [Full Text] [Related]
14. The predictive value of interleukin-8 (IL-8) in hospitalised patients with fever and chemotherapy-induced neutropenia.
Tromp YH; Daenen SM; Sluiter WJ; Vellenga E
Eur J Cancer; 2009 Mar; 45(4):596-600. PubMed ID: 19095436
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8, and TNF-alpha in febrile children with cancer and neutropenia.
Soker M; Colpan L; Ece A; Devecioğlu C; Haspolat K
Med Oncol; 2001; 18(1):51-7. PubMed ID: 11778970
[TBL] [Abstract][Full Text] [Related]
16. Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy.
Robertson MJ; Larson RA
Am J Med; 1988 Feb; 84(2):233-9. PubMed ID: 3407652
[TBL] [Abstract][Full Text] [Related]
17. Persistent fever after recovery from granulocytopenia in acute leukemia.
Talbot GH; Provencher M; Cassileth PA
Arch Intern Med; 1988 Jan; 148(1):129-35. PubMed ID: 3422147
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
Takeshita A; Saito H; Toyama K; Horiuchi A; Kuriya S; Furusawa S; Tsuruoka N; Takiguchi T; Matsuda T; Utsumi M; Shiku H; Matsui T; Egami K; Tamura K; Ohno R
Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623
[TBL] [Abstract][Full Text] [Related]
19. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.
de Bont ES; Vellenga E; Swaanenburg JC; Fidler V; Visser-van Brummen PJ; Kamps WA
Br J Haematol; 1999 Nov; 107(2):375-80. PubMed ID: 10583227
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of fever of unknown origin in patients with acute leukemia and granulocytopenia.
Nakase K; Tsuji K; Miyanishi E; Shirakawa S
Med Hypotheses; 1990 Dec; 33(4):235-7. PubMed ID: 2090923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
